The influence of VKORC1 and CYP2C9 mutations on warfarin response after total hip and knee arthroplasty.

about

The influence of VKORC1 and CYP2C9 mutations on warfarin response after total hip and knee arthroplasty.

Item

http://www.wikidata.org/entity/Q39124661

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

The influence of VKORC1 and CY ...... tal hip and knee arthroplasty.

@en

The influence of VKORC1 and CY ...... tal hip and knee arthroplasty.

@nl

type

Item

label

The influence of VKORC1 and CY ...... tal hip and knee arthroplasty.

@en

The influence of VKORC1 and CY ...... tal hip and knee arthroplasty.

@nl

prefLabel

The influence of VKORC1 and CY ...... tal hip and knee arthroplasty.

@en

The influence of VKORC1 and CY ...... tal hip and knee arthroplasty.

@nl

P1476

The influence of VKORC1 and CY ...... tal hip and knee arthroplasty.

@en

P2093

Colleen M Brophy

http://www.w3.org/2001/XMLSchema#string

Eric S Wise

http://www.w3.org/2001/XMLSchema#string

Justin K Nelms

http://www.w3.org/2001/XMLSchema#string

Robert J Wilson

http://www.w3.org/2001/XMLSchema#string

Stephen P Gadomski

http://www.w3.org/2001/XMLSchema#string

William G McMaster

http://www.w3.org/2001/XMLSchema#string

P2860

Influence of CYP2C9 and VKORC1 on patient response to warfarin: a systematic review and meta-analysis

Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee Registry

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

Changing practice of anticoagulation: will target-specific anticoagulants replace warfarin?

Implementation of pharmacogenetics: the University of Maryland Personalized Anti-platelet Pharmacogenetics Program.

Clinical pharmacogenetics implementation: approaches, successes, and challenges

Laboratory and clinical outcomes of pharmacogenetic vs. clinical protocols for warfarin initiation in orthopedic patients.

Genetic determinants of response to warfarin during initial anticoagulation

Genetic-based dosing in orthopedic patients beginning warfarin therapy.

Prevention of venous thromboembolic disease after total hip and knee arthroplasty.

P304

S145-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JOR.2015.10.023

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kyle M. Hocking

P577

2015-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27047214

http://www.w3.org/2001/XMLSchema#string

P932

4796661

http://www.w3.org/2001/XMLSchema#string